Andrew Huberman
@hubermanlab·7.5M subscribers·510 videos
Essentials: Psychedelics for Treating Mental Disorders | Dr. Matthew Johnson
Posted
July 24, 2025
Views
83,855
Likes
2,010
Comments
159
Engagement
July 24, 2025
83,855
2,010
159
2.59%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics.
We explore the science and therapeutic potential of psychedelic medicine, including psilocybin, MDMA and LSD. We discuss how these substances can profoundly alter perception and self-identity, providing long-lasting relief from depression, addiction and trauma when used in controlled clinical settings. We also discuss microdosing and emerging research on psychedelics’ potential to support recovery from neurological injuries.
Episode show notes
Huberman Lab Essentials are short episodes focused on essential science and protocol takeaways from past fulllength Huberman Lab episodes. Watch the fulllength episode
Watch more Huberman Lab Essentials episodes
*Follow Huberman Lab*
*Timestamps*
Disclaimer & Disclosures
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.